Citigroup Inc Novo Cure LTD Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Citigroup Inc holds 84,699 shares of NVCR stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,699

Previous 93,969 9.86%

Holding current value

$1.62 Million

Previous $2.8 Million 46.11%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$17.82 - $30.19 $165,191 - $279,861	-9,270 Reduced 9.86%	84,699 $1.51 Million
Q4 2024 Feb 12, 2025	BUY	$14.54 - $33.41 $165,188 - $379,571	11,361 Added 13.75%	93,969 $2.8 Million
Q3 2024 Nov 12, 2024	SELL	$15.61 - $23.34 $643,584 - $962,284	-41,229 Reduced 33.29%	82,608 $1.29 Million
Q2 2024 Aug 12, 2024	BUY	$11.83 - $24.05 $150,489 - $305,940	12,721 Added 11.45%	123,837 $2.12 Million
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $1.65 Million - $2.29 Million	-132,519 Reduced 54.39%	111,116 $1.74 Million
Q4 2023 Feb 09, 2024	BUY	$11.13 - $15.78 $2.23 Million - $3.16 Million	200,363 Added 463.03%	243,635 $3.64 Million
Q3 2023 Nov 09, 2023	SELL	$16.15 - $42.35 $703,542 - $1.84 Million	-43,563 Reduced 50.17%	43,272 $698,000
Q2 2023 Aug 10, 2023	SELL	$40.29 - $82.51 $483,480 - $990,120	-12,000 Reduced 12.14%	86,835 $3.6 Million
Q1 2023 May 11, 2023	SELL	$56.44 - $118.81 $235,185 - $495,081	-4,167 Reduced 4.05%	98,835 $5.94 Million
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $1.08 Million - $1.44 Million	16,905 Added 19.63%	103,002 $7.56 Million
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $357,559 - $471,048	5,259 Added 6.51%	86,097 $6.54 Million
Q2 2022 Aug 10, 2022	SELL	$56.6 - $89.9 $74,485 - $118,308	-1,316 Reduced 1.6%	80,838 $5.62 Million
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $3.99 Million - $5.61 Million	-66,411 Reduced 44.7%	82,154 $6.81 Million
Q4 2021 Feb 10, 2022	BUY	$75.08 - $121.99 $2.69 Million - $4.37 Million	35,806 Added 31.75%	148,565 $11.2 Million
Q3 2021 Nov 10, 2021	BUY	$116.17 - $194.55 $13.1 Million - $21.9 Million	112,759 New	112,759 $13.1 Million

Others Institutions Holding NVCR

# of Institutions

266

Shares Held

79.4M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.01B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account